(Q34639884)

3 August 2017

1 reference

title

Breast cancer and the immune system: opportunities and pitfalls (English)

1 reference

3 August 2017

Plunkett TA

1

1 reference

3 August 2017

Correa I

series ordinal

2

1 reference

3 August 2017

Miles DW

series ordinal

3

1 reference

3 August 2017

Taylor-Papadimitriou J

series ordinal

4

1 reference

3 August 2017

publication date

1 October 2001

1 reference

Journal of Mammary Gland Biology and Neoplasia

3 August 2017

published in

1 reference

3 August 2017

volume

6

1 reference

3 August 2017

issue

4

1 reference

3 August 2017

page(s)

467-475

1 reference

Phase-I study of synthetic muc1 peptides in breast-cancer

3 August 2017

cites work

1 reference

12 December 2020

Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells.

1 reference

12 December 2020

DNA vaccines: immunology, application, and optimization*

1 reference

12 December 2020

Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA.

1 reference

12 December 2020

Dendritic cells in cancer immunotherapy

1 reference

12 December 2020

High incidence of interleukin 10 mRNA but not interleukin 2 mRNA detected in human breast tumours

1 reference

12 December 2020

Phenotypic analysis of tumor-infiltrating lymphocytes from human breast cancer

1 reference

12 December 2020

Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara

1 reference

12 December 2020

Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte lines

1 reference

12 December 2020

Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer

1 reference

12 December 2020

Induction of tumor immunity and cytotoxic T lymphocyte responses using dendritic cells transfected with messenger RNA amplified from tumor cells

1 reference

12 December 2020

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma

1 reference

12 December 2020

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

1 reference

12 December 2020

Ganglioside vaccines with emphasis on GM2

1 reference

12 December 2020

Genetic prodrug activation therapy for breast cancer: A phase I clinical trial of erbB-2-directed suicide gene expression

1 reference

12 December 2020

Flow cytometric analysis of tumour infiltrating lymphocyte activation and tumour cell MHC Class I and II expression in breast cancer patients

1 reference

12 December 2020

Selectivity of a replication-competent adenovirus for human breast carcinoma cells expressing the MUC1 antigen.

1 reference

12 December 2020

Pathological prognostic factors in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma: a study of 644 patients with median follow-up of 18 years

1 reference

12 December 2020

Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer

1 reference

12 December 2020

In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas.

1 reference

12 December 2020

Induction of Polyclonal Prostate Cancer-Specific CTL Using Dendritic Cells Transfected with Amplified Tumor RNA

1 reference

12 December 2020

Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations

1 reference

12 December 2020

Antibody and T cell responses of patients with adenocarcinoma immunized with mannan-MUC1 fusion protein

1 reference

12 December 2020

Human tumor-infiltrating lymphocytes: a marker of host response.

1 reference

12 December 2020

Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial

1 reference

12 December 2020

Intramuscular immunisation with MUC1 cDNA can protect C57 mice challenged with MUC1-expressing syngeneic mouse tumour cells

1 reference

12 December 2020

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

1 reference

12 December 2020

Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease

1 reference

12 December 2020

Lymphoid infiltration as a prognostic variable for early-onset breast carcinomas

1 reference

12 December 2020

Expression of MHC class I and class II antigens in primary breast carcinomas and synchronous nodal metastases

1 reference

12 December 2020

In situ cytokine production by breast cancer tumor-infiltrating lymphocytes

1 reference

12 December 2020

Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids

1 reference

12 December 2020

Immunobiology of dendritic cells

1 reference

12 December 2020

Immunization with a peptide epitope (p369-377) from HER-2/neu leads to peptide-specific cytotoxic T lymphocytes that fail to recognize HER-2/neu+ tumors.

1 reference

12 December 2020

Active immunotherapy with allogeneic tumor cell vaccines: present status

1 reference

12 December 2020

Anti-MUC1 class I restricted CTLs in metastatic breast cancer patients immunized with a synthetic MUC1 peptide

1 reference

12 December 2020

Existent T-cell and antibody immunity to HER-2/neu protein in patients with breast cancer.

1 reference

12 December 2020

Antibodies against mucin-associated sialyl-Tn epitopes correlate with survival of metastatic adenocarcinoma patients undergoing active specific immunotherapy with synthetic STn vaccine

1 reference

12 December 2020

MUC1 cross-reactive Galα(l,3)Gal antibodies in humans switch immune responses from cellular to humoral

1 reference

12 December 2020

Induction of cytotoxic T-lymphocyte responses in vivo after vaccinations with peptide-pulsed dendritic cells

1 reference

12 December 2020

Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens

1 reference

12 December 2020

Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability

1 reference

12 December 2020

Antigen-processing machinery breakdown and tumor growth

1 reference

12 December 2020

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

12 December 2020

Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1014743232598

1 reference

Dimensions Publication ID

3 August 2017

1009521079

0 references

1 reference